Asia Pacific Specialty Generics Market Size, Share & Industry Trends Analysis Report By Type, By Application, By End Use, By Country and Growth Forecast, 2023

List of Tables

The Asia Pacific Specialty Generics Market would witness market growth of 10.6% CAGR during the forecast period (2023-2030).

The generic versions of pharmaceutical items are known as specialty generics. When compared to pharmaceuticals with a name brand, these drugs are less expensive. These medications include biopharmaceuticals, complicated compounds, and items obtained from blood. As various specialized drug compounds approach patent expiration in the next years, businesses are joining this industry to produce generic versions of the goods by developing new drug formulations.

Additionally, the traditional generic medicine industry's capacity is pressuring businesses to look for newer prospects. However, when compared to ordinary generics, the development and commercialization of specialty generics medications are more important. Governments are putting pressure on pharmaceutical producers to provide cost-effective medicines because healthcare costs have escalated as a result of expensive pharmaceutical products. One of the key elements boosting the market growth is the increased incidence of malignancies.

The number of people over 60 in India has more than tripled in the last 50 years. There were 103.83 million older adults, or those over 60, in 2011, based on the most recent data available from the Census. This figure is anticipated to rise to 178.59 million by 2031, then to 236.01 million, and eventually to 300.96 million. The World Health Organization reports that China has one of the world's fastest-aging populations. By 2040, there will be 28% of individuals in China who are over 60 as a result of rising life expectancy and falling fertility rates. There were 176 million older persons aged 65 or older and 254 million older people aged 60 or over in 2019. In 2040, there will be 402 million people over the age of 60, or 28% of the world's population. The market is expected to expand as a result of the growing elderly population in regional countries.

The China market dominated the Asia Pacific Specialty Generics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $11,154.4 million by 2030. The Japan market is estimated to grow a CAGR of 9.9% during (2023 - 2030). Additionally, The India market would register a CAGR of 11.2% during (2023 - 2030).

Based on Type, the market is segmented into Injectables, Oral Drugs, and Others. Based on Application, the market is segmented into Inflammatory conditions, Multiple sclerosis, Hepatitis C, Oncology, and Others. Based on End Use, the market is segmented into Specialty Pharmacy, Retail Pharmacy, and Hospital Pharmacy. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teva Pharmaceuticals Industries Ltd., Novartis AG, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Fresenius SE & Co. KGaA, Dr. Reddy's Laboratories Ltd., Mallinckrodt PLC, Bausch Health Companies, Inc., Viatris, Inc. and Apotex, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type

Injectables
Oral Drugs
Others

By Application

Inflammatory conditions
Multiple sclerosis
Hepatitis C
Oncology
Others

By End Use

Specialty Pharmacy
Retail Pharmacy
Hospital Pharmacy

By Country

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

Companies Profiled

Teva Pharmaceuticals Industries Ltd.
Novartis AG
Hikma Pharmaceuticals PLC
Sun Pharmaceutical Industries Ltd.
Fresenius SE & Co. KGaA
Dr. Reddy's Laboratories Ltd.
Mallinckrodt PLC
Bausch Health Companies, Inc.
Viatris, Inc.
Apotex, Inc.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Asia Pacific Specialty Generics Market, by Type
- 1.4.2 Asia Pacific Specialty Generics Market, by Application
- 1.4.3 Asia Pacific Specialty Generics Market, by End Use
- 1.4.4 Asia Pacific Specialty Generics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.2.4 Approvals and Trials
3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
- 3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2020, May - 2023, Jan) Leading Players

Chapter 4. Asia Pacific Specialty Generics Market by Type

4.1 Asia Pacific Injectables Market by Country
4.2 Asia Pacific Oral Drugs Market by Country
4.3 Asia Pacific Others Market by Country

Chapter 5. Asia Pacific Specialty Generics Market by Application

5.1 Asia Pacific Inflammatory conditions Market by Country
5.2 Asia Pacific Multiple sclerosis Market by Country
5.3 Asia Pacific Hepatitis C Market by Country
5.4 Asia Pacific Oncology Market by Country
5.5 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Specialty Generics Market by End Use

6.1 Asia Pacific Specialty Pharmacy Market by Country
6.2 Asia Pacific Retail Pharmacy Market by Country
6.3 Asia Pacific Hospital Pharmacy Market by Country

Chapter 7. Asia Pacific Specialty Generics Market by Country

7.1 China Specialty Generics Market
- 7.1.1 China Specialty Generics Market by Type
- 7.1.2 China Specialty Generics Market by Application
- 7.1.3 China Specialty Generics Market by End Use
7.2 Japan Specialty Generics Market
- 7.2.1 Japan Specialty Generics Market by Type
- 7.2.2 Japan Specialty Generics Market by Application
- 7.2.3 Japan Specialty Generics Market by End Use
7.3 India Specialty Generics Market
- 7.3.1 India Specialty Generics Market by Type
- 7.3.2 India Specialty Generics Market by Application
- 7.3.3 India Specialty Generics Market by End Use
7.4 South Korea Specialty Generics Market
- 7.4.1 South Korea Specialty Generics Market by Type
- 7.4.2 South Korea Specialty Generics Market by Application
- 7.4.3 South Korea Specialty Generics Market by End Use
7.5 Singapore Specialty Generics Market
- 7.5.1 Singapore Specialty Generics Market by Type
- 7.5.2 Singapore Specialty Generics Market by Application
- 7.5.3 Singapore Specialty Generics Market by End Use
7.6 Malaysia Specialty Generics Market
- 7.6.1 Malaysia Specialty Generics Market by Type
- 7.6.2 Malaysia Specialty Generics Market by Application
- 7.6.3 Malaysia Specialty Generics Market by End Use
7.7 Rest of Asia Pacific Specialty Generics Market
- 7.7.1 Rest of Asia Pacific Specialty Generics Market by Type
- 7.7.2 Rest of Asia Pacific Specialty Generics Market by Application
- 7.7.3 Rest of Asia Pacific Specialty Generics Market by End Use

Chapter 8. Company Profiles

8.1 Teva Pharmaceutical Industries Ltd.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.1.5 Recent strategies and developments:
  - 8.1.5.1 Partnerships, Collaborations, and Agreements:
  - 8.1.5.2 Product Launches and Product Expansions:
8.2 Novartis AG
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 Recent strategies and developments:
  - 8.2.5.1 Partnerships, Collaborations, and Agreements:
  - 8.2.5.2 Acquisition and Mergers:
8.3 Hikma Pharmaceuticals PLC
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 Recent strategies and developments:
  - 8.3.5.1 Partnerships, Collaborations, and Agreements:
  - 8.3.5.2 Product Launches and Product Expansions:
8.4 Sun Pharmaceutical Industries Ltd.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 Research & Development Expenses
- 8.4.5 Recent strategies and developments:
  - 8.4.5.1 Partnerships, Collaborations, and Agreements:
  - 8.4.5.2 Product Launches and Product Expansions:
8.5 Fresenius SE & Co. KGaA
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 Recent strategies and developments:
  - 8.5.5.1 Acquisition and Mergers:
8.6 Dr. Reddy's Laboratories Ltd.
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental and Regional Analysis
- 8.6.4 Research & Development Expense
- 8.6.5 Recent strategies and developments:
  - 8.6.5.1 Product Launches and Product Expansions:
8.7 Mallinckrodt PLC
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expense
- 8.7.5 Recent strategies and developments:
  - 8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Bausch Health Companies, Inc
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Segmental and Regional Analysis
- 8.8.4 Research & Development Expense
- 8.8.5 Recent strategies and developments:
  - 8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Viatris, Inc.
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 Recent strategies and developments:
  - 8.9.5.1 Partnerships, Collaborations, and Agreements:
8.10. Apotex, Inc.
- 8.10.1 Company Overview

LIST OF TABLES

TABLE 1 Asia Pacific Specialty Generics Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Specialty Generics Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Specialty Generics Market
TABLE 4 Product Launches And Product Expansions- Specialty Generics Market
TABLE 5 Acquisition and Mergers- Specialty Generics Market
TABLE 6 Approvals and Trials- Specialty Generics Market
TABLE 7 Asia Pacific Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 9 Asia Pacific Injectables Market by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Injectables Market by Country, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Oral Drugs Market by Country, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Oral Drugs Market by Country, 2023 - 2030, USD Million
TABLE 13 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 17 Asia Pacific Inflammatory conditions Market by Country, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Inflammatory conditions Market by Country, 2023 - 2030, USD Million
TABLE 19 Asia Pacific Multiple sclerosis Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Multiple sclerosis Market by Country, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Hepatitis C Market by Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Hepatitis C Market by Country, 2023 - 2030, USD Million
TABLE 23 Asia Pacific Oncology Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Oncology Market by Country, 2023 - 2030, USD Million
TABLE 25 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 27 Asia Pacific Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 28 Asia Pacific Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 29 Asia Pacific Specialty Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 30 Asia Pacific Specialty Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 31 Asia Pacific Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 32 Asia Pacific Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 33 Asia Pacific Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 34 Asia Pacific Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 35 Asia Pacific Specialty Generics Market by Country, 2019 - 2022, USD Million
TABLE 36 Asia Pacific Specialty Generics Market by Country, 2023 - 2030, USD Million
TABLE 37 China Specialty Generics Market, 2019 - 2022, USD Million
TABLE 38 China Specialty Generics Market, 2023 - 2030, USD Million
TABLE 39 China Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 40 China Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 41 China Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 42 China Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 43 China Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 44 China Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 45 Japan Specialty Generics Market, 2019 - 2022, USD Million
TABLE 46 Japan Specialty Generics Market, 2023 - 2030, USD Million
TABLE 47 Japan Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 48 Japan Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 49 Japan Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 50 Japan Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 51 Japan Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 52 Japan Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 53 India Specialty Generics Market, 2019 - 2022, USD Million
TABLE 54 India Specialty Generics Market, 2023 - 2030, USD Million
TABLE 55 India Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 56 India Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 57 India Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 58 India Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 59 India Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 60 India Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 61 South Korea Specialty Generics Market, 2019 - 2022, USD Million
TABLE 62 South Korea Specialty Generics Market, 2023 - 2030, USD Million
TABLE 63 South Korea Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 64 South Korea Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 65 South Korea Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 66 South Korea Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 67 South Korea Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 68 South Korea Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 69 Singapore Specialty Generics Market, 2019 - 2022, USD Million
TABLE 70 Singapore Specialty Generics Market, 2023 - 2030, USD Million
TABLE 71 Singapore Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 72 Singapore Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 73 Singapore Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 74 Singapore Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 75 Singapore Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 76 Singapore Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 77 Malaysia Specialty Generics Market, 2019 - 2022, USD Million
TABLE 78 Malaysia Specialty Generics Market, 2023 - 2030, USD Million
TABLE 79 Malaysia Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 80 Malaysia Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 81 Malaysia Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 82 Malaysia Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 83 Malaysia Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 84 Malaysia Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 85 Rest of Asia Pacific Specialty Generics Market, 2019 - 2022, USD Million
TABLE 86 Rest of Asia Pacific Specialty Generics Market, 2023 - 2030, USD Million
TABLE 87 Rest of Asia Pacific Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 88 Rest of Asia Pacific Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 89 Rest of Asia Pacific Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 90 Rest of Asia Pacific Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 91 Rest of Asia Pacific Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 92 Rest of Asia Pacific Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 93 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 94 Key Information - Novartis AG
TABLE 95 Key Information - Hikma Pharmaceuticals PLC
TABLE 96 Key Information - Sun Pharmaceutical Industries Ltd.
TABLE 97 key information - Fresenius SE & Co. KGaA
TABLE 98 key information - Dr. Reddy's Laboratories Ltd.
TABLE 99 Key information - Mallinckrodt PLC
TABLE 100 key information - Bausch Health Companies, Inc.
TABLE 101 key information - Viatris, Inc.
TABLE 102 Key Information - Apotex, Inc.

List of Figures

FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions: 2020, May - 2023, Jan) Leading Players
FIG 5 Asia Pacific Specialty Generics Market share by Type, 2022
FIG 6 Asia Pacific Specialty Generics Market share by Type, 2030
FIG 7 Asia Pacific Specialty Generics Market by Type, 2019 - 2030, USD Million
FIG 8 Asia Pacific Specialty Generics Market share by Application, 2022
FIG 9 Asia Pacific Specialty Generics Market share by Application, 2030
FIG 10 Asia Pacific Specialty Generics Market by Application, 2019 - 2030, USD Million
FIG 11 Asia Pacific Specialty Generics Market share by End Use, 2022
FIG 12 Asia Pacific Specialty Generics Market share by End Use, 2030
FIG 13 Asia Pacific Specialty Generics Market by End Use, 2019 - 2030, USD Million
FIG 14 Asia Pacific Specialty Generics Market share by Country, 2022
FIG 15 Asia Pacific Specialty Generics Market share by Country, 2030
FIG 16 Asia Pacific Specialty Generics Market by Country, 2019 - 2030, USD Million
FIG 17 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
FIG 18 Recent strategies and developments: Novartis AG
FIG 19 Recent strategies and developments: Hikma Pharmaceuticals PLC
FIG 20 Recent strategies and developments: Sun Pharmaceutical Industries Ltd.

Asia Pacific Specialty Generics Market Size, Share & Industry Trends Analysis Report By Type, By Application, By End Use, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents